Aberrant laminin β3 isoforms downstream of EWS-ETS fusion genes in ewing family tumors

Cancer Biology and Therapy

Volumn 4, Issue 4, 2005, Pages 449-455

  Irifune, Hideto ^a   Nishimori, Hiroyuki ^a   Watanabe, Goichi ^a   Yoshida, Kouichi ^a   Ikeda, Tatsuru ^b   Matsui, Chihiro ^c   Morohashi, Masaaki ^c   Kawaguchi, Satoshi ^a   Nagoya, Satoshi ^a   Wada, Takuro ^a   Yamashita, Toshihiko ^a   Nakamura, Yusuke ^d   Tokino, Takashi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY HOSPITAL   (Japan)

^c TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anchorage independent proliferation; Antisense oligonucleotide; cDNA microarray; Ewing family tumors; EWS ETS fusion genes; Laminin 3 isoform

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; HYBRID PROTEIN; ISOPROTEIN; KALININ; LAMININ; MEMBRANE PROTEIN; MESSENGER RNA; RETROVIRUS VECTOR; RNA BINDING PROTEIN EWS; TRANSCRIPTION FACTOR ETS; CELL ADHESION MOLECULE; ONCOPROTEIN;

ARTICLE; BASEMENT MEMBRANE; BETA CHAIN; CANCER CELL CULTURE; CANCER INVASION; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; EWING SARCOMA; FIBROSARCOMA; GENE; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE FUSION; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; INTRON; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; ONCOGENE; PROMOTER REGION; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TARGETING; UPREGULATION; ANIMAL; COMPARATIVE STUDY; GENETICS; METABOLISM; MOUSE; PATHOLOGY; RETROVIRUS; TUMOR CELL LINE;

ANIMALS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CLONING, MOLECULAR; HUMANS; MICE; NIH 3T3 CELLS; OLIGONUCLEOTIDES, ANTISENSE; ONCOGENE PROTEINS, FUSION; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-ETS; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; RNA, MESSENGER; RNA-BINDING PROTEIN EWS; SARCOMA, EWING'S;

EID: 25144514454     PISSN: 15384047     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, et al. Gene fusion with an ETS DNA-binding domain caused, by chromosome translocation in human tumours. Nature 1992; 359:162-5.
2. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, et al. The Ewing family of tumors - a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994; 331:294-9.
3. Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XP, Triche TJ, Denny CT. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 1994; 6:146-51.
4. Giovannini M, Biegel JA, Serra M, Wang JY, Wei YH, Nycum L, et al. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations. J Clin Invest 1994; 94:489-96.
5. Jeon IS, Davis JN, Braun BS, Sublett JE, Roussel MF, Denny CT, et al. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 1995; 10:1229-34.
6. Urano F, Umezawa A, Hong W, Kikuchi H, Hata J. A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing's sarcoma. Biochem Biophys Res Commun 1996; 219:608-12.
7. Kaneko Y, Yoshida K, Handa M, Toyoda Y, Nishihira H, Tanaka Y, et al. Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer 1996; 15:115-21.
8. Peter M, Couturier J, Pacquement H, Michon J, Thomas G, Magdelenat H, et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 1997; 14:1159-64.
9. Ouchida M, Ohno T, Fujimura Y, Rao VN, Reddy ES. Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts. Oncogene 1995; 11:1049-54.
10. Kovar H, Aryee DN, Jug G, Henockl C, Schemper M, Delattre O, et al. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro. Cell Growth Differ 1996; 7:429-37.
11. Tanaka K, Iwakuma T, Harimaya K, Sato H, Iwamoto Y. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells. J Clin Invest 1997; 99:239-47.
12. May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O, et al. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci USA 1993; 90:5752-6.
13. May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, et al. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 1993; 13:7393-8.
14. May WA, Arvand A, Thompson AD, Braun BS, Wright M, Denny CT. EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic. Nat Genet 1997; 17:495-7.
15. Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG, et al. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet 1999; 23:222-7.
16. Arvand A, Bastians H, Welford SM, Thompson AD, Ruderman JV, Denny CT. EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene 1998; 17:2039-45.
17. Thompson AD, Braun BS, Arvand A, Stewart SD, May WA, Chen E, et al. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene. Oncogene 1996; 13:2649-58.
18. Zwerner JP, May WA. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors. Oncogene 2001; 20:626-33.
19. Dauphinot L, De Oliveira C, Melot T, Sevenet N, Thomas V, Weissman BE, et al. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Oncogene 2001; 20:3258-65.
20. Nakatani F, Tanaka K, Sakimura R, Matsumoto Y, Matsunobu T, Li X, et al. Identification of p21WAF1/CIP1 as a direct target of EWS-Flil oncogenic fusion protein. J Biol Chem 2003; 278:15105-15.
21. Deneen B, Welford SM, Ho T, Hernandez F, Kurland I, Denny CT. PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins. Mol Cell Biol 2003; 23:3897-908.
22. Nishimori H, Sasaki Y, Yoshida K, Irifune H, Zembutsu H, Tanaka T, et al. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene 2002; 21:8302-9.
23. Watanabe G, Nishimori H, Irifune H, Sasaki Y, Ishida S, Zembutsu H, et al. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes. Genes Chromosomes Cancer 2003; 36:224-32.
24. Verrando P, Pisani A, Ortonne JP. The new basement membrane antigen recognized by the monoclonal antibody GB3 is a large size glycoprotein: Modulation of its expression by retinoic acid. Biochim Biophys Acta 1988; 942:45-56.
25. Rousselle P, Lunstrum GP, Keene DR, Burgeson RE. Kalinin: An epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments. J Cell Biol 1991; 114:567-76.
26. Marinkovich MP, Lunstrum GP, Burgeson RE. The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J Biol Chem 1992; 267:17900-6.
27. Marinkovich MP, Verrando P, Keene DR, Meneguzzi G, Lunstrum GP, Ortonne JP, et al. Basement membrane proteins kalinin and nicein are structurally and immunologically identical. Lab Invest 1993; 69:295-9.
28. Urano F, Umezawa A, Yabe H, Hong W, Yoshida K, Fujinaga K, et al. Molecular analysis of Ewing's sarcoma: Another fusion gene, EWS-E1AF, available for diagnosis. Jpn J Cancer Res 1998; 89:703-11.
29. Ono K, Tanaka T, Tsunoda T, Kitahara O, Kihara C, Okamoto A, et al. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res 2000; 60:5007-11.
30. Kihara C, Tsunoda T, Tanaka T, Yamana H, Furukawa Y, Ono K, et al. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 2001; 61:6474-9.
31. Ishida S, Yamashita T, Nakaya U, Tokino T. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells. Jpn J Cancer Res 2000; 91:174-80.
32. Kikkawa Y, Umeda M, Miyazaki K. Marked stimulation of cell adhesion and motility by ladsin, a laminin-like scatter factor. J Biochem (Tokyo) 1994; 116:862-9.
33. Masunaga T, Shimizu H, Matsui C, Aozaki R, Morohashi M, Yasumoto S, et al. LAMB3 gene transfection into SV40-transformed keratinocytes from patient with Herlitz junctional epidermolysis bullosa. Arch Dermatol Res 2000; 292:195-7.
34. Moriya Y, Niki T, Yamada T, Matsuno Y, Kondo H, Hirohashi S. Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. An immunohistochemical analysis of 102 cases. Cancer 2001; 91:1129-41.
35. Timpl R. Structure and biological activity of basement membrane proteins. Eur J Biochem 1989; 180:487-502.
36. Beck K, Hunter I, Engel J. Structure and function of laminin: Anatomy of a multidomain glycoprotein. Faseb J 1990; 4:148-60.
37. Pyke C, Romer J, Kallunki P, Lund LR, Ralfkiaer E, Dano K, et al. The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol 1994; 145:782-91.
38. Pyke C, Salo S, Ralfkiaer E, Romer J, Dano K, Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res 1995; 55:4132-9.
39. Sordat I, Bosman FT, Dorta G, Rousselle P, Aberdam D, Blum AL, et al. Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia. J Pathol 1998; 185:44-52.
40. Koshikawa N, Moriyama K, Takamura H, Mizushima H, Nagashima Y, Yanoma S, et al. Overexpression of laminin gamma 2 chain monomer in invading gastric carcinoma cells. Cancer Res 1999; 59:5596-601.
41. Soini Y, Maatta M, Salo S, Tryggvason K, Autio-Harmainen H. Expression of the laminin gamma 2 chain in pancreatic adenocarcinoma. J Pathol 1996; 180:290-4.
42. Skyldberg B, Salo S, Eriksson E, Aspenblad U, Moberger B, Tryggvason K, et al. Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 1999; 91:1882-7.
43. Kosmehl H, Berndt A, Strassburger S, Borsi L, Rousselle P, Mandel U, et al. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br J Cancer 1999; 81:1071-9.
44. Ono Y, Nakanishi Y, Ino Y, Niki T, Yamada T, Yoshimura K, et al. Clinocopathologic significance of laminin-5 gamma2 chain expression in squamous cell carcinoma of the tongue: Immunohistochemical analysis of 67 lesions. Cancer 1999; 85:2315-21.
45. Kainulainen T, Autio-Harmainen H, Oikarinen A, Salo S, Tryggvason K, Salo T. Altered distribution and synthesis of laminin-5 (kalinin) in oral lichen planus, epithelial dysplasias and squamous cell carcinomas. Br J Dermatol 1997; 136:331-6.
46. Wayner EA, Gil SG, Murphy GF, Wilke MS, Carter WG. Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J Cell Biol 1993; 121:1141-52.
47. Delwel GO, de Melker AA, Hogervorst F, Jaspars LH, Fles DL, Kuikman I, et al. Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: Recognition of laminin isoforms. Mol Biol Cell 1994; 5:203-15.
48. Niessen CM, Hogervorst F, Jaspars LH, de Melker AA, Delwel GO, Hulsman EH, et al. The alpha 6 beta 4 integrin is a receptor for both laminin and kalinin. Exp Cell Res 1994; 211:360-7.
49. Rousselle P, Keene DR, Ruggiero F, Champliaud MF, Rest M, Burgeson RE. Laminin 5 binds the NC-1 domain of type VII collagen. J Cell Biol 1997; 138:719-28.
50. Lohi J. Laminin-5 in the progression of carcinomas. Int J Cancer 2001; 94:763-7.
51. Sharrocks AD, Brown AL, Ling Y, Yates PR. The ETS-domain transcription factor family. Int J Biochem Cell Biol 1997; 29:1371-87.
52. Graves BJ, Petersen JM. Specificity within the ets family of transcription factors. Adv Cancer Res 1998; 75:1-55.
53. McNagny KM, Sieweke MH, Doderlein G, Graf T, Nerlov C. Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1. EMBO J 1998; 17:3669-80.
54. Pulkkinen L, Gerecke DR, Christiano AM, Wagman DW, Burgeson RE, Uitto J. Cloning of the beta 3 chain gene (LAMB3) of human laminin 5, a candidate gene in junctional epidermolysis bullosa. Genomics 1995; 25:192-8.